McGill University Medical Podcast Series
Matthew Dankner - Dual MAPK inhibition in a subset of BRAF mutant melanomas


Published online: 10 September 2018
1 Faculty of Medicine, McGill University, Montréal, Canada.
Corresponding Author: Russel Yanofsky, email russ.yanofsky@gmail.com.

Episode 3

In this episode, we're joined by MD/PhD student Matthew Dankner to discuss his paper "Dual MAPK inhibition is an effective therapeutic strategy for a subset of class II BRAF mutant melanoma " published in the June 2018 issue of Clinical Cancer Research..

Article: Matthew Dankner, Mathieu Lajoie, Dan Moldoveanu, Tan-Trieu Nguyen, Paul Savage, Shivshankari Rajkumar, Xiu Huang, Maria Lvova, Alexei Protopopov, Dana Vuzman, David Hogg, Morag Park, Marie-Christine Guiot, Kevin Petrecca, Catalin Mihalcioiu, Ian R. Watson, Peter M. Siegel and April A. N. Rose. Dual MAPK inhibition is an effective therapeutic strategy for a subset of class II BRAF mutant melanoma. Clin Cancer Res June 14 2018 DOI: 10.1158/1078-0432.CCR-17-3384 10.1158/1078-0432.CCR-17-3384